RxDoctor Payments Data

Mary Pine, PA

Physician Assistant · Sunnyside, WANPI 1649388588

Payments from drug & device makers

$4,347in general payments, 2019–2025

Across 213 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Boehringer Ingelheim$621
  • Lilly USA, LLC$488
  • Pfizer$387
  • Novo Nordisk$324
  • Bayer$182
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$4,347100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,347 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$49,791
Medicare patients
187
Services billed
1,232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide169$271,718
JardianceEmpagliflozin54$91,234
FarxigaDapagliflozin Propanediol66$81,227
JanuviaSitagliptin Phosphate43$48,588
OzempicSemaglutide37$44,700
TrulicityDulaglutide37$43,875
Bydureon BciseExenatide Microspheres33$36,984
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$32,035
MyrbetriqMirabegron25$28,896
XareltoRivaroxaban15$27,366
EliquisApixaban34$27,157
Nurtec OdtRimegepant Sulfate12$21,653
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen378$15,094
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$13,225
Spiriva RespimatTiotropium Bromide12$6,724

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$488$315,593206 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,158$113,26299 claims
Boehringer IngelheimJardiance, Spiriva Respimat$621$97,95866 claims
PfizerEliquis, Nurtec Odt$387$48,81046 claims
MerckJanuvia$46$48,58843 claims
Novo NordiskOzempic$324$44,70037 claims
Johnson & JohnsonXarelto$161$27,36615 claims
GSKTrelegy Ellipta$105$13,22512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Sunnyside

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →